Full KardiaChain tokenomics breakdown: KAI token allocation, vesting schedule, supply distribution, unlock dates, and investor terms.
Comprehensive breakdown of all investment rounds, pricing terms, and vesting schedules
Key questions and answers about KardiaChain tokenomics.
KardiaChain token distribution allocates 5,000,000,000 KAI across 5 primary stakeholder groups:
KAI uses variable cliffs and vesting schedules that change depending on the allocation:
15% of the total supply (750,000,000 KAI) is unlocked at TGE, with the entire unlock going to Public Sale.
KardiaChain has a total supply of 5,000,000,000 KAI, of which 4,775,000,000 KAI (95.5% of total) is currently circulating.
Total length of the full KardiaChain emission schedule is 4 years, with 25.88% released in Year 1, while the remaining 39.12% is released over the following 3 years.
KardiaChain has 2 investor rounds, with the following investment price and vesting:
5% of the KardiaChain supply is allocated to community focused pools such as Community.
KardiaChain is an innovative blockchain platform that introduces a groundbreaking dual-node, non-invasive architecture to achieve unmatched interoperability. By enabling the seamless transfer of data and assets between blockchains and traditional systems, KardiaChain aims to become the ultimate enterprise-grade solution for businesses and developers worldwide. At the heart of KardiaChain lies $KAI, its native utility token, essential for powering the ecosystem’s operations. KardiaChain's tokenomics model is carefully designed to drive adoption, reward stakeholders, and sustain long-term ecosystem growth. $KAI serves multiple core functions, including transaction fees within the network, staking for consensus building, and rewarding validators. Users can stake $KAI tokens to support network security while earning rewards, promoting an active and decentralized community. Additionally, $KAI tokens are integral to deploying and executing smart contracts, making them a vital element of the platform’s decentralized application ecosystem. KardiaChain is renowned for its unique non-invasive approach to interoperability, which ensures that partner blockchains don’t need significant protocol modifications to connect to the KardiaChain network. This feature dramatically reduces integration barriers and attracts more developers and businesses to the platform. Its scalability solutions further empower developers to create high-performance decentralized applications (dApps) that cater to real-world enterprise demands. Furthermore, the platform features an optimized token distribution mechanism, ensuring equitable resource allocation and incentivizing participation. $KAI token holders gain governance rights, providing them the ability to vote on important network proposals, contributing to the platform’s decentralization and transparency. These mechanisms position KardiaChain and $KAI as a robust solution for scaling blockchain technology. With a strong focus on enterprise-directed solutions, KardiaChain stands out as a versatile, interoperable blockchain with advanced technical features. Its seamless design bridges the gap between blockchain networks and non-blockchain systems, making KardiaChain a pioneering force in the decentralized technology landscape.